Clinically oriented approach to a child with abdominal mass.
Discussion about Neuroblastoma
Discussion about Wilms tumor
Discussion about Hepatic tumors
Case discussions
Approach to patient with spinal cord lesions & diseases
Localize spinal cord lesions
Determining the Level of the Lesion in Myelopathy
Diseases of spinal cord
This is a comprehensive approach to a hypertensive patient presenting to the emergency department.
Discussing:-
- Hypertensive emergency
- Hypertensive Urgency
- Hypertensive Crisis
- Hypertensive encephalopathy and retinopathy
- Accelerated Hypertension
- Malignant hypertension
this is a complete discussion and an approach to a child with febrile seizure / convulsion.
It contains:-
Case scenario
Causes of Seizures in the setting of fever
Definition of Febrile Seizure
Age of Occurrence
Types of Febrile Convulsions
Risks of Recurrent Febrile Seizures
Risk For Developing Epilepsy After Febrile Seizures
Workup for Febrile Seizure
Red Flags in Febrile Seizures
Treatment
Prognosis
Approach to Syncope in Children (Pediatric Syncope).pptxJwan AlSofi
Approach to Syncope in Children (Pediatric Syncope), includes:-
Introduction
Differential diagnosis of syncope
Syncope vs vertigo vs Presyncope vs light-headedness.
Comparison of Clinical Features of Syncope and Seizures
Neurocardiogenic (Vasovagal) syncope
MECHANISMS and Causes of Syncope
Cardiac causes of syncope
Life-threatening causes of syncope
Red Flags in Evaluation of Patients With Syncope
Non-cardiac causes of loss of consciousness.
Noncardiac Causes of Syncope
Differentiating Features for Causes of Syncope
EVALUATION of syncope:- History, Examination,Treatment.
Summary
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...VarunMahajani
Disruption of blood supply to lung alveoli due to blockage of one or more pulmonary blood vessels is called as Pulmonary thromboembolism. In this presentation we will discuss its causes, types and its management in depth.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stockrebeccabio
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Telegram: bmksupplier
signal: +85264872720
threema: TUD4A6YC
You can contact me on Telegram or Threema
Communicate promptly and reply
Free of customs clearance, Double Clearance 100% pass delivery to USA, Canada, Spain, Germany, Netherland, Poland, Italy, Sweden, UK, Czech Republic, Australia, Mexico, Russia, Ukraine, Kazakhstan.Door to door service
Hot Selling Organic intermediates
Approach to a Child with an Abdominal Mass and tumours.pptx
1. APPROACH TO A CHILD
WITH AN ABDOMINAL MASS
AND TUMOURS
By
Jwan Ali Ahmed AlSofi
2. Contents:-
• Clinically oriented approach to a child with abdominal mass.
• Discussion about Neuroblastoma
• Discussion about Wilms tumor
• Discussion about Hepatic tumors
• Case discussion
3. The following points need to be considered
when assessing a child with an abdominal mass:
1. Age of the patient and the most likely pathological process
arising in that organ at that age
2. Length of history and type of symptoms, which may also
implicate a particular pathological process (e.g. tenderness of the
mass suggests infection or bleeding)
3. Site of the mass and its precise characteristics, which will
suggest the probable organ of origin
5. Normal and abnormal abdominal masses:-
• The most common abdominal masses in infancy and childhood are non-pathological.
They are usually accounted for by
1. Liver, which normally extends below the right costal margin until 3–4 years of age;
2. Faeces in the colon;
3. Full bladder.
• Three common pathological conditions often present with an abdominal mass in
childhood:
1. Wilms tumour (nephroblastoma),
2. Abdominal neuroblastoma
3. Hydronephrosis.
6.
7. Pathological conditions have certain
features in common:-
1. They are most common in infants and toddlers between 1
and 3 years of age.
2. The mass is typically large when first detected as the
normally protuberant infantile abdomen may conceal
masses of smaller sizes.
3. The mass itself is usually the presenting feature, while
general or local symptoms are typically minimal or
absent.
Neuroblastoma is an exception to the this point: a significant
number of children with neuroblastoma present systemically unwell,
including failure to thrive.
8. DDX of a mass according to its site:-
•A mass situated in the midline in the upper abdomen:-
1. Is most likely a primary abdominal neuroblastoma,
particularly if the child is less than 4 years of age.
2. Massive hepatic metastases (e.g. from a primary neuroblastoma)
3. Primary hepatoblastoma.
•Masses arising in the loin can be palpated extending below
the rib margin towards the iliac fossa and are most likely due
to
1. Hydronephrosis
2. Wilms tumour.
10. Stepwise Evaluation of an Abdominal Mass
Clinical History
•Age and gender
•General symptoms
•Pain
•Gastrointestinal symptoms
•Urogenital symptoms
•Pulmonary symptoms
•Family history
•Sexual history
•Weight loss
•Travel
Physical Examination
•General condition
•Lymph nodes
•Associated physical findings
•Cachexia
Abdominal Palpation
•Quadrant of the abdomen
•Organ most likely to be affected
•Characteristics (soft or hard,
mobile or nonmobile, crosses
midline, moves with respiration,
tender)
11.
12. Investigations
• Blood tests:-
- CBC,
- electrolyte analysis
- tumour markers.
• Plain abdominal x-ray
▫ May show calcification within the mass, which is more common in neuroblastoma than Wilms tumour,
and does not occur in hydronephrosis, unless there is a renal stone.
• Abdominal ultrasonography.
▫ Determine whether a mass is cystic or solid
▫ Documents the size, position and extent of a solid tumour and may demonstrate blood vessel involvement
(e.g. extension of a Wilms tumour into the inferior vena cava).
▫ Lymph node involvement and metastases may be demonstrated
• (MRI) and angiography to determine vascular supply have select roles.
• Abdominal (CT) for oncological purposes.
• Nuclear scan:-
- To quantify relative function of each kidney in cases of renal mass/ hydronephrosis
- Reveal the obstruction of the renal tract (MAG3 renogram to investigate hydronephrosis)
13.
14.
15. •Neuroblastoma
▫ Is the most common extra-cranial solid tumour of childhood.
▫ The most common malignancy in infancy.
•The median age at diagnosis is 17 months.
•It is an embryonal tumour that arises from fetal neural crest cells –
neural crest cells form the adrenal medulla and the sympathetic nervous system
•It may occur at any site in the sympathetic nervous system.
•The most common primary sites are
▫ the adrenal gland,
▫ Elsewhere in the abdomen,
▫ the sympathetic chain or the sympathetic plexus in the mediastinum or pelvis.
•Neuroblastoma has wide variety of possible presentations because of :-
1. The numerous sites of primary tumour
2. propensity to early metastasis.
16. Tumour behaviour:-
•Metastases are present in 70% of patients at diagnosis and may
be in the
- bone marrow – Bone and bone marrow are the most frequent sites of metastasis
- cortex of long bones
- lymph nodes – regional or distant,
- skull, eyes,
- Liver
- skin.
•In view of the invasiveness and malignant potential of neuroblastoma
it is a paradox that, in a minority of cases, the tumour regresses
completely with a spontaneous cure.
This unusual tumour behaviour is restricted to children with clinical stage
MS (previously called stage 4S), which is defined as:-
1. Younger than 18 months
2. Presents with metastases strictly confined to the skin, liver and/or bone
marrow.
17. Presentations:-
• Systemic complaints such as fever, weight loss, ill-appearing and pain – more with metastases.
• The most common presentation is abdominal pain or mass.
▫ The mass is often palpated in the abdomen or flank and is hard and nontender.
• Palpable skull nodule due to skull metastases
• Proptosis and periorbital ecchymoses due to ocular metastases
• Horner syndrome due to involvement of the stellate ganglion (sympathetic chain)
• Paraplegia of rapid onset due to intraspinal extension of a paravertebral primary
• Rubbery lymph nodes in the neck or axilla due to lymph node metastases
• Long bone pain and tenderness due to bony metastases
• Bone marrow involvement manifesting as any or all of pain, limping, paralysis or weakness and
failure to thrive with or without anaemia
• Blueberry muffin spots on the skin of infants due to skin metastases
• Diarrhoea caused by tumour metabolites, for example, (VIP)
• Paraneoplastic syndromes:-
▫ secretory diarrhea,
▫ profuse sweating
▫ Opsomyoclonus
18. • Blueberry muffin spots:-
▫ Is the description given to the skin
metastases of Neuroblastoma
▫ Are pathognomonic for clinical stage
MS
Racoon eyes in
neuroblastoma
with CT scan
showing the
tumor
22. Diagnostic criteria:-
The diagnosis of neuroblastoma requires one or both of the following
criteria:
1. Unequivocal pathologic diagnosis from tumour tissue or raised serum
catecholamines (i.e. dopamine, adrenaline, noradrenaline) or raised urinary
catecholamine metabolites (VMA, HVA)
2. Unequivocal pathologic evidence for bone marrow involvement (evident in
65–75% cases at presentation) together with either raised serum
catecholamines or raised urinary catecholamine metabolites
23. Investigations:-
CBC – anemia, thrombocytopenia, or neutropenia, because of bone marrow
involvement.
Plain radiographs – Calcification within abdominal neuroblastoma tumors
Urinary catecholamines (vanillylmandelic acid; homovanillic acid)
Biopsy. While the diagnosis of neuroblastoma may be made without tumour
biopsy, tissue biopsy for tumour histology and biological features is essential for
risk stratification.
Abdominal CT to look for image-defined risk factors as a part of clinical staging.
Metaiodobenzylguanidine (MIBG) nuclear scan / Bone scan. Identifies
both primary and metastatic lesions.
CT chest, abdomen, and pelvis. Inspect for metastases.
Bilateral bone marrow aspiration and biopsies
25. DIFFERENTIAL DIAGNOSIS:-
1. The abdominal presentation of neuroblastoma must be differentiated from Wilms
tumor, which also presents as an abdominal or flank mass.
2. Periorbital ecchymoses from orbital metastases can be mistaken for child abuse.
3. Because children with bone marrow involvement may have anemia, thrombocytopenia,
or neutropenia, leukemia is often considered in the differential.
25
26. Treatment:-
1. Observation only: this is limited to a select group of patients, typically in the under
18-month age group with stage MS disease.
2. Operative excision alone: also limited to a select group of patients.
3. Operative excision with neo-adjuvant and adjuvant chemotherapy: this is
the most common treatment pathway and may be complemented by autologous stem
cell transplant.
4. Radiotherapy: usually reserved for high-risk disease in addition to operative
excision and chemotherapy.
5. Biological and immunological therapies are an increasingly important
component of the treatment regimen in neuroblastoma – usually limited to high- risk
patients and patients with recurrent disease.
27. Prognosis
• The prognosis is highly dependent upon the stage of disease at presentation.
• High-risk disease is currently associated with a 5-year survival rate of 50%.
• Compared with toddlers and older children, infants with neuroblastoma are generally
well, have less aggressive disease, and an excellent prognosis.
28.
29. • Wilms tumour, or nephroblastoma of the kidney, is the most common renal
malignancy in childhood.
• It arises from primitive embryonic metanephric blastemal – the
precursor of a normal kidney.
• The classical location for Wilms tumor is the kidney.
• Rare extrarenal sites:- retroperitoneum, sacrococcygeal region, testis, uterus,
inguinal canal and mediastinum.
• Produces the classic histologic pattern “triphasic”, composed of
- Epithelial structures resembling tubules,
- Blastemal elements of small blue cells,
- Stromal- mesenchymal tissues, including striated muscle fibres ments.
• Wilms tumour is typically sporadic in origin.
• However, it may be associated with a number of syndromes.
• Bilateral disease
▫ is present in 6% of affected children.
▫ More commonly associated with hereditary forms of the disease
▫ Considered stage V.
30.
31.
32. Certain syndromes are at increased risk of
developing Wilms Tumor including:-
1. Beckwith-Wiedemann
2. WAGR (Wilms tumor, aniridia, genitourinary anomalies, and
retardation; mutation involving 11p13 region)
32
34. Clinical features:-
• Classic history – abdominal mass found during dressing or bathing
A smooth loin mass that seldom crosses the midline, but extends down into the iliac fossa and up
under the costal margin.
A right- sided Wilms tumour may extend behind the liver, which, if pushed down, may present as
hepatomegaly.
On the left side, a Wilms tumour may be mistaken for an enlarged spleen.
• Children with Wilms tumours are typically well at presentation (80% of cases),
unlike those patients with neuroblastoma.
• Haematuria, often following minor trauma, is the presentation in some children, but
does not indicate a poorer prognosis.
• Elevated blood pressure, may be due to unusual metabolites from the tumour
tissue or compression of the renal vessels
• Pulmonary involvement is the most common metastatic site
35.
36. Investigation:-
• CBC, urinalysis, liver and renal function studies
• Ultrasonography provides detailed information of the site, size and extent of the tumour.
• Doppler ultrasonography also identifies renal vein and inferior vena cava involvement.
Evaluation of the inferior vena cava is crucial because the tumor may extend from the kidney into
the vena cava.
• The liver is examined for the presence of metastases.
• CXR excludes the presence of pulmonary metastases.
• A contrast CT scan of the abdomen, chest and pelvis is utilised to
▫ assess the extent of disease,
▫ the involvement of the contralateral kidney,
▫ the effect on surrounding tissues
▫ the extent of metastatic disease.
• Preoperative tissue diagnosis. Controversy.
▫ In US, primary resection without a prior tissue diagnosis is the routine. The operative and histological
findings then direct the need for subsequent chemotherapy and radiotherapy.
▫ In Europe, preoperative chemotherapy is initiated without a tissue diagnosis.
39. Treatment:-
• Treatment of Wilms tumor is nephrectomy and chemotherapy with or without
radiation therapy.
• The timing of Wilms tumour surgery relative to biopsy and/or chemotherapy remains
controversial.
▫ The North American approach recommends an upfront nephrectomy (confirming tissue diagnosis)
followed by adjuvant chemotherapy with or without radiation therapy, whereas the
▫ European approach is to make a diagnosis relying predominantly on imaging (sometimes a
biopsy), provide upfront (neoadjuvant) chemotherapy, then nephrectomy of the involved kidney
followed by adjuvant chemotherapy with or without radiation therapy.
1. Tumour nephrectomy is an integral component of successful Wilms tumour
management. By an open and transabdominal approach.
2. Chemotherapy
3. Radiotherapy
40. Prognosis
• Wilms tumours, in contrast to neuroblastoma, are associated with excellent rates of
survival.
• Cure rates for stage I are as high as 95%, and even in those with stage V disease, the cure
rates approach 75%.
• Late recurrence is rare.
• Patients must be followed for the late effects associated with both chemotherapy and
radiotherapy.
46. Hepatoblastoma
• is the most common malignant tumour presenting as a right upper quadrant mass in children less
than 1 year of age.
• Differential diagnoses include
▫ Haemangioendothelioma (the most common benign vascular tumour of the liver in infancy,
typically presenting before 6 months of age)
▫ Mesenchymal hamartoma (a benign tumour that almost exclusively occurs in children under 2 years
of age).
• The mass in an infant with hepatoblastoma is typically large.
• The infant may also present with systemic features such as weight loss, vomiting and anaemia.
• Elevation of the tumour marker serum alpha-fetoprotein in a patient with a liver mass strongly
suggests hepatoblastoma.
• Accurate preoperative imaging is necessary, including ultrasonography, CT scan, MRI and
angiography.
• Operative resection of the lesion, either locally or by lobectomy, remains the main treatment for all
primary liver tumours, but preoperative chemotherapy significantly improves survival.
• There is almost no chance of cure in hepatoblastoma patients without complete resection.
47. KEY POINTS
•A child with an abdominal mass needs immediate clinical assessment and
investigation to exclude malignancy.
•Abdominal masses in toddlers may be huge before diagnosis.
•Ultrasonography is an effective screening test for malignancy.
•A patient with a presumed abdominal tumour needs immediate referral to
the regional surgical and oncology centre.
48.
49.
50.
51. Answers:-
1.1 Hydronephrosis.
1.2 Renal ultrasound, nuclear renal scan ± cystoscopy with retrograde pyelogram to
distinguish pelvi-ureteric junction obstruction from vesico-ureteric junction obstruction.
2.1 Wilms tumour or neuroblastoma, once ultrasound confirms lesion is solid.
2.2 Biopsy/excision and chemotherapy ± radiotherapy.
3.1 Catecholamine measurements (VMA, HMA) in urine, CT scan, bone scan, bone marrow
and FBE; neuroblastoma.
3.2 Prognosis is poor, but some are still curable with chemotherapy and surgery.
Editor's Notes
Cystic masses may be seen with hydronephrosis, multilocular or simple renal cysts, multicystic dysplastic kidneys or a dilated renal pelvis from high-grade vesicoureteric reflux.